Delivery Order SPE2DB20D2014-SPE2DB25FA30Z

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML to the Defense Logistics Agency (DLA). The firm-fixed-price Delivery Order, valued at $1,227.36, has an ultimate completion date of January 22, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,821.14 firm fixed price delivery order is for 4566054659 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a completion date of March 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,369.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 21, 2024 with a completion date of March 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The $1,144.85 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,837.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 29, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.05 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,133.73 delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has a firm fixed price and a completion date of May 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.30 firm-fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has a completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA30Z
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,944.00 firm fixed-price delivery order has a completion date of November 12, 2024 and was awarded on November 8, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/7/25, 9:18 AM